A potential silver lining of delaying the second dose

A potential silver lining of delaying the second dose

A delayed second dose relative to the standard 3-week schedule for the BNT162b2 mRNA vaccine against SARS-CoV-2 significantly raises the levels of neutralizing antibodies against SARS-CoV-2 variants.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature immunology 2022-03, Vol.23 (3), p.349-351
Hauptverfasser: Martinez, David R., Ooi, Eng Eong
Format: Artikel
Sprache:eng
Schlagworte:
631/250/255/2514
631/250/590/2293
Biomedical and Life Sciences
Biomedicine
BNT162 Vaccine
COVID-19
COVID-19 Vaccines
Humans
Immunity, Humoral
Immunology
Infectious Diseases
News & Views
news-and-views
RNA, Messenger
T-Lymphocytes
Vaccination
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A delayed second dose relative to the standard 3-week schedule for the BNT162b2 mRNA vaccine against SARS-CoV-2 significantly raises the levels of neutralizing antibodies against SARS-CoV-2 variants.
ISSN:1529-2908
1529-2916
DOI:10.1038/s41590-022-01143-z